ASCO GU 2024: Darolutamide + ADT + docetaxel effective, well-tolerated SoC for mHSPC
14 Jun 2024
ASCO GU 2024: Darolutamide + ADT + docetaxel effective, well-tolerated SoC for mHSPC
ASCO GU 2024: Darolutamide + ADT + docetaxel effective, well-tolerated SoC for mHSPC